Dehydroepiandrosterone reduces expression of glycolytic and gluconeogenic enzymes in the liver of male and female rats

International Journal of Oncology

Volumn 8, Issue 6, 1996, Pages 1069-1078

  Mayer, Doris ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

dehydroepiandrosterone (DHEA); glucose metabolising enzymes; rat liver

Indexed keywords

PRASTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GLUCONEOGENESIS; GLUCOSE METABOLISM; GLYCOLYSIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0029903121     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. Baulieu EE: Studies of conjugated 17-ketosteroids in a case of adrenal tumour. J Clin Endocrinol Metab 22: 501-510, 1962.
2. Schwartz AG, Whitcomb JM, Nyce JW, Lewhart ML and Pashko LL: Dehydroepiandrosterone and structural analogs: a new class of cancer preventive agents. Adv Cancer Res 51: 391-424, 1088.